Login / Signup

Identification of α-Synuclein Proaggregator: Rapid Synthesis and Streamlining RT-QuIC Assays in Parkinson's Disease.

Fumito TakadaTakahito KasaharaKentaro OtakeTakamitsu MaruMasanori MiwaKei MutoMinoru SasakiYoshihiko HirozaneMasato YoshikawaJunichiro Yamaguchi
Published in: ACS medicinal chemistry letters (2022)
We report the discovery of two compounds, TKD150 and TKD152, that promote the aggregation of α-synuclein (aSN) using a real-time quaking-induced conversion (RT-QuIC) assay to detect abnormal aSN. By utilizing a Pd-catalyzed C-H arylation of benzoxazole with iodoarenes and implementing a planar conformation to the design, we successfully identified TKD150 and TKD152 as proaggregators for aSN. In comparison to a previously reported proaggregator, PA86, the two identified compounds were able to promote aggregation of aSN at twice the rate. Application of TKD150 and TKD152 to the RT-QuIC assay will shorten the inherent lag time and may allow wider use of this assay in clinical settings for the diagnosis of α-synucleinopathy-related diseases.
Keyphrases
  • high throughput
  • high glucose
  • quality improvement
  • room temperature
  • oxidative stress
  • endothelial cells
  • drug induced
  • clinical evaluation
  • stress induced
  • sensitive detection